What is the Share Price of Godavari Drugs Ltd?
- Answer Field
-
The share price of Godavari Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 94.95.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, GODAVARI DRUGS LTD. share price is currently at ₹ 94.95, which is up by ₹ 0.29 from its previous closing. Today, the stock has fluctuated between ₹ 93.00 and ₹ 95.80. Over the past year, GODAVARI DRUGS LTD. has achieved a return of -4.48 %. In the last month alone, the return has been 1.04 %. Read More...
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand.
The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals.
The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).
The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO.
In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.
The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale to
pilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
The share price of Godavari Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 94.95.
The market cap of Godavari Drugs Ltd for NSE is ₹ 0.00 Cr. and for BSE is ₹ 71.50 Cr. as of now.
The 52 Week High and Low of Godavari Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 155.00 and ₹ 79.00.
You can trade in Godavari Drugs Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -4.48%.
Godavari Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 94.95 as on Jun 13 2025 03:30 PM.
The market cap of Godavari Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 71.50 as on Jun 13 2025 03:30 PM.
As on Jun 13 2025 03:30 PM the price-to-earnings (PE) ratio for Godavari Drugs Ltd share is 16.31.
As on Jun 13 2025 03:30 PM, the price-to-book (PB) ratio for Godavari Drugs Ltd share is 57.56.
You can trade in Godavari Drugs Ltd shares with Bajaj Broking by opening a demat account.
To buy Godavari Drugs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Godavari Drugs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found